CFB
DGX icon

Cullen/Frost Bankers’s Quest Diagnostics DGX Stock Holding History

Cullen/Frost Bankers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Buy
91
+1
+1% +$196 ﹤0.01% 1065
2026
Q1 		$17.7K Hold
90
– – ﹤0.01% 1010
2025
Q4 		$15.7K Buy
90
+14
+18% +$2.55K ﹤0.01% 1056
2025
Q3 		$14.5K Sell
76
-1,000
-93% -$177K ﹤0.01% 1007
2025
Q2 		$193K Buy
1,076
+17
+2% +$2.95K ﹤0.01% 534
2025
Q1 		$179K Buy
1,059
+59
+6% +$9.69K ﹤0.01% 525
2024
Q4 		$151K Hold
1,000
– – ﹤0.01% 533
2024
Q3 		$155K Hold
1,000
– – ﹤0.01% 537
2024
Q2 		$137K Hold
1,000
– – ﹤0.01% 538
2024
Q1 		$133K Hold
1,000
– – ﹤0.01% 542
2023
Q4 		$138K Hold
1,000
– – ﹤0.01% 528
2023
Q3 		$122K Hold
1,000
– – ﹤0.01% 584
2023
Q2 		$141K Buy
1,000
+995
+19,900% +$137K ﹤0.01% 567
2023
Q1 		$707 Hold
5
– – ﹤0.01% 1152
2022
Q4 		$782 Hold
5
– – ﹤0.01% 1060
2022
Q3 		$1K Buy
+5
New +$658 ﹤0.01% 1080
2022
Q2 		– Sell
-17
Closed -$2K – 1098
2022
Q1 		$2K Buy
+17
New +$2.37K ﹤0.01% 1047
2020
Q4 		– Sell
-11
Closed -$1K – 1083
2020
Q3 		$1K Buy
+11
New +$1.3K ﹤0.01% 1073
2020
Q2 		– Sell
-116
Closed -$9K – 1103
2020
Q1 		$9K Sell
116
-21
-15% -$2.17K ﹤0.01% 735
2019
Q4 		$15K Sell
137
-423
-76% -$44.1K ﹤0.01% 834
2019
Q3 		$60K Sell
560
-96
-15% -$9.86K ﹤0.01% 538
2019
Q2 		$67K Sell
656
-1,272
-66% -$122K ﹤0.01% 522
2019
Q1 		$173K Buy
+1,928
New +$167K 0.01% 400
2018
Q4 		– Sell
-2,163
Closed -$233K – 393
2018
Q3 		$233K Buy
2,163
+175
+9% +$19.2K 0.01% 378
2018
Q2 		$218K Buy
+1,988
New +$207K 0.01% 396

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Cullen/Frost Bankers's DGX Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, buying an estimated $196 and bringing the position to 91 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Cullen/Frost Bankers first reported a position in DGX in Q2 2018 and has held it in 25 quarters since. The position peaked at $233K in Q3 2018. 675 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cullen/Frost Bankers held 91 shares of Quest Diagnostics worth $19.2K as of Q2 2026.
  • Cullen/Frost Bankers bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1065 holding.
  • Cullen/Frost Bankers first reported a position in Quest Diagnostics in Q2 2018 and has held it in 25 quarters since.
  • Cullen/Frost Bankers's Quest Diagnostics position peaked at $233K in Q3 2018.
  • 675 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.